Ono Pharmaceutical Co Stock Market Value

OPHLF Stock  USD 12.50  1.20  10.62%   
Ono Pharmaceutical's market value is the price at which a share of Ono Pharmaceutical trades on a public exchange. It measures the collective expectations of Ono Pharmaceutical Co investors about its performance. Ono Pharmaceutical is trading at 12.50 as of the 11th of December 2024. This is a 10.62 percent increase since the beginning of the trading day. The stock's lowest day price was 12.5.
With this module, you can estimate the performance of a buy and hold strategy of Ono Pharmaceutical Co and determine expected loss or profit from investing in Ono Pharmaceutical over a given investment horizon. Check out Ono Pharmaceutical Correlation, Ono Pharmaceutical Volatility and Ono Pharmaceutical Alpha and Beta module to complement your research on Ono Pharmaceutical.
Symbol

Please note, there is a significant difference between Ono Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ono Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ono Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Ono Pharmaceutical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ono Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ono Pharmaceutical.
0.00
11/11/2024
No Change 0.00  0.0 
In 31 days
12/11/2024
0.00
If you would invest  0.00  in Ono Pharmaceutical on November 11, 2024 and sell it all today you would earn a total of 0.00 from holding Ono Pharmaceutical Co or generate 0.0% return on investment in Ono Pharmaceutical over 30 days. Ono Pharmaceutical is related to or competes with Sanofi ADR, Bristol Myers, AstraZeneca PLC, Gilead Sciences, and Novartis. Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnos... More

Ono Pharmaceutical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ono Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ono Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.

Ono Pharmaceutical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Ono Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ono Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Ono Pharmaceutical historical prices to predict the future Ono Pharmaceutical's volatility.
Hype
Prediction
LowEstimatedHigh
4.4012.5020.60
Details
Intrinsic
Valuation
LowRealHigh
2.4610.5618.66
Details
Naive
Forecast
LowNextHigh
4.7712.8720.97
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.6111.4413.27
Details

Ono Pharmaceutical Backtested Returns

At this point, Ono Pharmaceutical is moderately volatile. Ono Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of 0.0062, which implies the firm had a 0.0062% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Ono Pharmaceutical, which you can use to evaluate the volatility of the company. Please check Ono Pharmaceutical's Coefficient Of Variation of (2,027), risk adjusted performance of (0.03), and Variance of 37.87 to confirm if the risk estimate we provide is consistent with the expected return of 0.049%. The company holds a Beta of 0.47, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Ono Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ono Pharmaceutical is expected to be smaller as well. Ono Pharmaceutical right now holds a risk of 7.92%. Please check Ono Pharmaceutical skewness, as well as the relationship between the day median price and relative strength index , to decide if Ono Pharmaceutical will be following its historical price patterns.

Auto-correlation

    
  -0.68  

Very good reverse predictability

Ono Pharmaceutical Co has very good reverse predictability. Overlapping area represents the amount of predictability between Ono Pharmaceutical time series from 11th of November 2024 to 26th of November 2024 and 26th of November 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ono Pharmaceutical price movement. The serial correlation of -0.68 indicates that around 68.0% of current Ono Pharmaceutical price fluctuation can be explain by its past prices.
Correlation Coefficient-0.68
Spearman Rank Test-0.5
Residual Average0.0
Price Variance1.45

Ono Pharmaceutical lagged returns against current returns

Autocorrelation, which is Ono Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ono Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Ono Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Ono Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Ono Pharmaceutical regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ono Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ono Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ono Pharmaceutical pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Ono Pharmaceutical Lagged Returns

When evaluating Ono Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ono Pharmaceutical pink sheet have on its future price. Ono Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ono Pharmaceutical autocorrelation shows the relationship between Ono Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Ono Pharmaceutical Co.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Ono Pink Sheet

Ono Pharmaceutical financial ratios help investors to determine whether Ono Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ono with respect to the benefits of owning Ono Pharmaceutical security.